Literature DB >> 15759148

Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.

Daisuke Yanase1, Ichiro Matsunari, Kazuyoshi Yajima, Weiping Chen, Akihiko Fujikawa, Shintaro Nishimura, Hiroshi Matsuda, Masahito Yamada.   

Abstract

PURPOSE: The aim of this study was to investigate the effects of atrophy correction on the results of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) in the context of normal aging.
METHODS: Before the human study was performed, a Hoffman 3D brain phantom experiment was carried out in order to validate a newly developed correction method for partial volume effects (PVEs). Brain FDG PET was then performed in 139 healthy Japanese volunteers (71 men, 68 women; age 24-81 years). PET images were corrected for PVEs using grey matter volume, which was segmented from co-registered magnetic resonance images and convoluted with the spatial resolution of the PET scanner. We investigated the correlation between advancing age and relative regional FDG activity, which was normalised to the global activity before and after PVE correction using Statistical Parametric Mapping 99.
RESULTS: The PET image, when corrected for PVEs, provided more homogeneous tracer distribution in the whole phantom than in the original PET image. The human PET study of both sexes revealed significant negative correlations between age and relative FDG activity in the bilateral perisylvian and medial frontal areas before PVE correction. However, these negative correlations were largely resolved after PVE correction.
CONCLUSION: Correction for PVEs was effective in our FDG PET study. The reduction in FDG uptake with advancing age that was detected by FDG PET without PVE correction could be accounted for largely by an age-related cerebral volume loss in the bilateral perisylvian and medial frontal areas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759148     DOI: 10.1007/s00259-005-1767-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  37 in total

1.  Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging.

Authors:  M Bentourkia; A Bol; A Ivanoiu; D Labar; M Sibomana; A Coppens; C Michel; G Cosnard; A G De Volder
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

2.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

3.  Correction for partial-volume effects on brain perfusion SPECT in healthy men.

Authors:  Hiroshi Matsuda; Takashi Ohnishi; Takashi Asada; Zhi-jie Li; Hidekazu Kanetaka; Etsuko Imabayashi; Fumiko Tanaka; Seigo Nakano
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

4.  Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.

Authors:  C Labbé; J C Froment; A Kennedy; J Ashburner; L Cinotti
Journal:  Alzheimer Dis Assoc Disord       Date:  1996       Impact factor: 2.703

5.  Neocortical cell counts in normal human adult aging.

Authors:  R D Terry; R DeTeresa; L A Hansen
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

6.  Quantitative synaptic alterations in the human neocortex during normal aging.

Authors:  E Masliah; M Mallory; L Hansen; R DeTeresa; R D Terry
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

7.  Gender differences in cerebellar metabolism: test-retest reproducibility.

Authors:  N D Volkow; G J Wang; J S Fowler; R Hitzemann; N Pappas; K Pascani; C Wong
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

8.  Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.

Authors:  D E Kuhl; E J Metter; W H Riege; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1982       Impact factor: 6.200

9.  Cerebral glucose metabolic rates in normal human females versus normal males.

Authors:  L R Baxter; J C Mazziotta; M E Phelps; C E Selin; B H Guze; L Fairbanks
Journal:  Psychiatry Res       Date:  1987-07       Impact factor: 3.222

10.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

Authors:  V Ibáñez; P Pietrini; G E Alexander; M L Furey; D Teichberg; J C Rajapakse; S I Rapoport; M B Schapiro; B Horwitz
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  34 in total

1.  Age-related metabolic profiles in cognitively healthy elders: results from a voxel-based [18F]fluorodeoxyglucose-positron-emission tomography study with partial volume effects correction.

Authors:  P K Curiati; J H Tamashiro-Duran; F L S Duran; C A Buchpiguel; P Squarzoni; D C Romano; H Vallada; P R Menezes; M Scazufca; G F Busatto; T C T F Alves
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

Review 2.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

Review 3.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

4.  Age-related morphology trends of cortical sulci.

Authors:  Peter Kochunov; Jean-François Mangin; Thomas Coyle; Jack Lancaster; Paul Thompson; Dennis Rivière; Yann Cointepas; Jean Régis; Anita Schlosser; Don R Royall; Karl Zilles; John Mazziotta; Arthur Toga; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2005-11       Impact factor: 5.038

5.  Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging.

Authors:  José V Pardo; Joel T Lee; Sohail A Sheikh; Christa Surerus-Johnson; Hemant Shah; Kristin R Munch; John V Carlis; Scott M Lewis; Michael A Kuskowski; Maurice W Dysken
Journal:  Neuroimage       Date:  2007-01-25       Impact factor: 6.556

6.  Aging and the interaction of sensory cortical function and structure.

Authors:  Ann M Peiffer; Christina E Hugenschmidt; Joseph A Maldjian; Ramon Casanova; Ryali Srikanth; Satoru Hayasaka; Jonathan H Burdette; Robert A Kraft; Paul J Laurienti
Journal:  Hum Brain Mapp       Date:  2009-01       Impact factor: 5.038

7.  Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging.

Authors:  Douglas N Greve; David H Salat; Spencer L Bowen; David Izquierdo-Garcia; Aaron P Schultz; Ciprian Catana; J Alex Becker; Claus Svarer; Gitte M Knudsen; Reisa A Sperling; Keith A Johnson
Journal:  Neuroimage       Date:  2016-02-23       Impact factor: 6.556

8.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

9.  Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction.

Authors:  Stijn Bonte; Pieter Vandemaele; Stijn Verleden; Kurt Audenaert; Karel Deblaere; Ingeborg Goethals; Roel Van Holen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-23       Impact factor: 9.236

Review 10.  Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.

Authors:  Valentina Berti; Lisa Mosconi; Alberto Pupi
Journal:  PET Clin       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.